Table 3.
Demographics and baseline characteristics
| Variable | Parameter | Treatment Group (n = 37) | Placebo Group (n = 15) |
| Gender, n (%) | Female | 20 (54.1) | 10 (67.0) |
| Male | 17 (45.9) | 5 (33.0) | |
| Age | Mean ± SD | 76.3 ± 7.8 | 74.7 ± 5.9 |
| Range | 54 to 90 | 66 to 85 | |
| Ethnicity, n (%) | African American | 1 (2.7) | 0 (0) |
| Asian | 1 (2.7) | 0 (0) | |
| Caucasian | 34 (91.9) | 15 (100) | |
| Hispanic | 1 (2.7) | 0 (0) | |
| Current smoker, n (%) | No | 37 (100) | - |
| Former smoker, n (%) | No | 25 (67.6) | - |
| Yes | 11 (29.7) | - | |
| Yes, 27 years ago | 1 (2.7) | - | |
| Family history of MD, n (%) | Yes | 9 (24.3) | - |
| Diabetes | Yes | 4 (10.8) | - |
| Hypertension | Yes | 16 (43.2) | - |
| Heart Disease | Yes | 13 (35.1) | - |
| Other | Yes | 31 (83.8) | - |
| Cataract surgery | Yes | 31 (83.8) | - |
| Refractive surgery | Yes | 0 (0) | - |
| Glaucoma | Yes | 8 (10.8) | - |
| Diabetic retinopathy | Yes | 0 (0) | - |
| Mean baseline BCVA (logMAR) | Mean ± SD | 0.41 ± 0.17 | 0.39 ± 0.17 |